文献速递心胸血管麻醉神经外科与老年麻醉

静脉利多卡因未改善心脏手术后神经学结局:随机对照试验

Intravenous Lidocaine Does Not Improve Neurologic Outcomes after Cardiac Surgery: A Randomized Controlled Trial.
PubMed 文献 · Anesthesiology · 2019-01-01

这项多中心随机双盲安慰剂对照试验纳入478例心脏手术患者,比较静脉利多卡因与安慰剂对术后认知功能的影响。6周随访时,利多卡因组与安慰剂组的连续认知评分变化无差异,认知缺陷发生率分别为41%和40%,1年随访仍无差异。

要点

  • 静脉利多卡因未减少心脏手术后6周认知功能下降。
  • 6周认知缺陷发生率利多卡因组41% vs 安慰剂组40%,无差异。
  • 1年随访认知评分、认知缺陷及生活质量均无差异。

核心结论

  • 心脏手术期间及术后静脉给予利多卡因未减少术后6周认知功能下降。

研究设计与样本

  • 多中心、前瞻性、随机、双盲、安慰剂对照、平行组试验,纳入478例心脏手术患者。

主要发现

  • 6周随访420例(利多卡因组211例,安慰剂组209例),连续认知评分变化调整后均值差0.02(95%CI -0.05至0.08),P=0.626。
  • 6周认知缺陷(至少一个认知域下降大于1个标准差)发生率利多卡因组41%(87/211) vs 安慰剂组40%(83/209),调整后比值比0.94(95%CI 0.63至1.41),P=0.766。
  • 两组生活质量结局无差异,1年随访认知评分变化、认知缺陷或生活质量仍无差异。

临床怎么用

  • 不支持将静脉利多卡因用于心脏手术患者以预防术后认知功能下降。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cognitive decline after cardiac surgery occurs frequently and persists in a significant proportion of patients. Preclinical studies and human trials suggest that intravenous lidocaine may confer protection in the setting of neurologic injury. It was hypothesized that lidocaine administration would reduce cognitive decline after cardiac surgery compared to placebo. METHODS: After institutional review board approval, 478 patients undergoing cardiac surgery were enrolled into this multicenter, prospective, randomized, double-blinded, placebo-controlled, parallel group trial. Subjects were randomized to lidocaine 1 mg/kg bolus after the induction of anesthesia followed by a continuous infusion (48 μg · kg · min for the first hour, 24 μg · kg · min for the second hour, and 10 μg · kg · min for the next 46 h) or saline with identical volume and rate changes to preserve blinding. Cognitive function was assessed preoperatively and at 6 weeks and 1 yr postoperatively using a standard neurocognitive test battery. The primary outcome was change in cognitive function between baseline and 6 weeks postoperatively, adjusting for age, years of education, baseline cognition, race, and procedure type. RESULTS: Among the 420 allocated subjects who returned for 6-week follow-up (lidocaine: N = 211; placebo: N = 209), there was no difference in the continuous cognitive score change (adjusted mean difference [95% CI], 0.02 (-0.05, 0.08); P = 0.626). Cognitive deficit (greater than 1 SD decline in at least one cognitive domain) at 6 weeks occurred in 41% (87 of 211) in the lidocaine group versus 40% (83 of 209) in the placebo group (adjusted odds ratio [95% CI], 0.94 [0.63, 1.41]; P = 0.766). There were no differences in any quality of life outcomes between treatment groups. At the 1-yr follow-up, there continued to be no difference in cognitive score change, cognitive deficit, or quality of life. CONCLUSIONS: Intravenous lidocaine administered during and after cardiac surgery did not reduce postoperative cognitive decline at 6 weeks.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Klinger RY, Cooter M, Bisanar T, et al. Intravenous Lidocaine Does Not Improve Neurologic Outcomes after Cardiac Surgery: A Randomized Controlled Trial. Anesthesiology. 2019. PMID: 30870159. doi:10.1097/ALN.0000000000002668

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。